The Academy of Oncology Nurse & Patient Navigators®
2022 Live & Virtual Simulcast Midyear Conference
May 11-15, 2022 | Austin, TX
POST TEST AND CLAIMING CE's for AONN+ MIDYEAR HAS EXPIRED.
Program Overview
This activity will be planned and implemented through The Academy of Oncology Nurse and Patient Navigators (AONN+), AKH Inc., Advancing Knowledge in Healthcare (AKH), and Center of Excellence Media (COE).
The Academy of Oncology Nurse & Patient Navigators® (AONN+) will be hosting the 2022 Midyear Conference, May 11-15, 2022, both live in Austin, Texas and via a virtual simulcast for those who cannot join in person. The program will be certified for up to 15.0 contact hours of CE credit. This will be a 4-day hybrid conference that will provide a forum for an open dialogue among nurse navigators in attendance who are involved in providing navigation and survivorship care services for patients with cancer. It will foster discussion regarding the complexities of the cancer care continuum, including financial considerations, access to screening and treatment, the impact of personalized care, psychosocial considerations, and the challenges of various healthcare delivery models. Additionally, this conference will lead to new ideas and potential ways to improve the delivery of navigation and survivorship care services. General and breakout sessions will focus on the various components involved in optimal patient navigation and will provide a wide array of perspectives on these issues.
To further extend the educational reach of the meeting, highlights from the 2022 virtual conference will developed as a Monograph and disseminated to the full AONN membership and the oncology nursing community as a CE-certified 8-12-page supplement that will appear in the Journal of Oncology Navigation & Survivorship®, The Oncology Nurse-APN/PA®, as well as in a digital format on the journal websites: www.TheOncologyNurse.com ; http://www.jons-online.com/
Target Audience
This educational initiative is intended for hematology/oncology nurse navigators, patient navigators, and social workers whose focus is on cancer care and survivorship. It will also be useful for nurse practitioners, oncology nurses, advanced practice nurses, and other healthcare professionals involved in managing patients with cancer.
Learning Objectives
Upon completion of the AONN+ 2022 Midyear Virtual Conference, participants should be able to:
Preconference Workshop 1 | LGBTQ
Preconference Workshop 2 | Powerful Conversations
General Session 1 | Indigenous People Oncology Care
General Session 2| AYA Tumor Board
General Session 3 | Navigating Global Patients
BOLD: Mentorship Academy “Building Oncology Leadership & Development and Networking Session
General Session 4 | Evolution of Navigation
General Session 5 | Oral Chemotherapy
General Session 6 | Implementing a Transportation Hub: A Holistic Approach to a Systemic Problem
General Session 7 | Leveraging GU Navigation in Urology Group
Breakout Session 1 | New to Navigation
Breakout Session 2 | The Hope More Spa
General Session 8 |The Disco App- A Patient Focused Tool to Reduce Financial Toxicity
General Session 9 | Resiliency and Self-Care
Criteria for Success
Certificates of completion will be awarded based on the participant’s attendance, participation in the pre/post-test and submission of the activity evaluation/claim credit form which will be provided at the end of the conference.
Please claim your credit by June 15th, 2022.
If you have questions about this CE activity, please contact AKH Inc. at kwolynski@akhcme.com
CE Credit provided by AKH Inc., Advancing Knowledge in Healthcare
"In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare, Center of Excellence Media, LLC and The Academy of Oncology Nurse Navigators, Inc. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team."
Nurses
Credit being awarded: 15.0 ANCC contact hours
As a Jointly Accredited Organization, AKH Inc., Advancing Knowledge in Healthcare is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. AKH Inc. Advancing Knowledge in Healthcare maintains responsibility for this course. Social workers completing this course receive 15.0 continuing education credits.
Disclosure
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
FACULTY/ PLANNER/REVIEWER DISCLOSURES |
||
Jerilyn Arneson, PharmD, BCOP |
N/A |
Nothing to disclose |
Kris Astroff, BA |
N/A |
Nothing to disclose |
Nikki Barkett, BSN, RN, OCN |
N/A |
Nothing to disclose |
Natalie Bucklin, BS (Patient Speaker) |
N/A |
Nothing to disclose |
Mary Buffington, MSN, RN, OCN, ONN-CG |
N/A |
Nothing to disclose |
Linda Burhansstipanov, MSPH, DrPH |
N/A |
Nothing to disclose |
Tony Burns (Patient Speaker) |
N/A |
Nothing to disclose |
Marco Carlos, MA, OPN-CG |
N/A |
Nothing to disclose |
Jeanna Doyle |
N/A |
Nothing to disclose |
Sharon Gentry, MSN, HON-ONNCG, AOCN |
N/A |
Nothing to disclose |
Valerie Guzman, MA |
N/A |
Nothing to disclose |
Lauren Hamel, PhD |
N/A |
Nothing to disclose |
Deidra Hamilton, MSN, RN, OCN, ONN-CG |
N/A |
Nothing to disclose |
Elizabeth Harris, MBA |
N/A |
Nothing to disclose |
Jordan Henderson BSN, RN, OCN, ONN-CG |
N/A |
Nothing to disclose |
Rachel Marquez, MPH |
N/A |
Nothing to disclose |
Ann Moenke, MPA |
N/A |
Nothing to disclose |
Mandi Pratt-Chapman, MA, PhD, OPN-CG |
Consultant/Grants Review |
Novartis |
Jess Quiring, CN-BA, OPN-CG |
N/A |
Nothing to disclose |
Asa Radix, MD, PhD, MPH |
N/A |
Nothing to disclose |
Paula Sanborn, MS, APRN, FNP-C, CPHON, ONN-CG |
N/A |
Nothing to disclose |
Angie Santiago, CRCS |
N/A |
Nothing to disclose |
Ryan Soisson, MA Organization Develop |
N/A |
Nothing to disclose |
Megan Solinger, MHS, MA, OPN-CG |
N/A |
Nothing to disclose |
Erica Williams, BSN, RN, OCN, CBCN |
N/A |
Nothing to disclose |
Dorothy Caputo, MA, BSN, RN - Sr Director, Continuing Education & Compliance - (Reviewer) |
N/A |
Nothing to disclose |
Broc Pollinger MSW, LSW, OSW-C – (Social Work Reviewer) |
N/A |
Nothing to disclose |
AKH Planners and Reviewers / COE Staff and AONN Planners |
N/A |
Nothing to disclose |
All of the relevant financial relationships listed for these individuals have been mitigated. |
||
Commercial Support
This activity is supported by an educational funding from Amgen, AstraZeneca, Eisai, GlaxoSmithKline, Merck Sharp & Dohme LLC, Novartis Pharmaceuticals Corporation. and Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com. All other grant support will be disclosed prior to the start of the conference.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.